Liver Transplant Plenary
Saturday, November 5th
Time: 9:00 - 10:30 AM EDT
Room: Room 151
About the Session
This liver transplant plenary session provides the opportunity for the audience to hear the latest state-of-the-art information on recent studies related to organ allocation and preservation, immunosuppression, and outcomes of transplantation in different hepatic disorders and malignancies in adults and children.
- The audience will learn about effect of race on GFR equations, and impact of renal dysfunction on MELD score and liver allocation.
- The audience will learn about multi-organ dysfunction in patients with ACLF and its impact on liver transplant outcomes.
- The audience will learn about the impact of newer MELD variants on waitlist mortality risk in adolescent liver transplant registrants, and patients with hepatocellular carcinoma.
- RANDOMIZED CONTROLLED TRIAL OF LOW CALORIE VS. LOW CARBOHYDRATE DIET ON METABOPHENOTYPE IN LIVER TRANSPLANT RECIPIENTS WITH OBESITY
- ASSESSMENT OF KIDNEY FUNCTION IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: DOES REMOVING RACE VARIABLE IMPROVE PERFORMANCE OF NEW GFR EQUATIONS?
- NOT ALL MELD SCORES ARE CREATED EQUAL: MELD DRIVEN BY CREATININE HAS LOWER INTENT TO TREAT SURVIVAL COMPARED TO MELD DRIVEN BY BILIRUBIN OR INR
- MELD 3.0 PREDICTS WAITLIST MORTALITY RISK IN ADOLESCENT LIVER TRANSPLANT REGISTRANTS
- THE MULTI-ORGAN DYSFUNCTION AND EVALUATION FOR LIVER TRANSPLANTATION (MODEL) SCORE PREDICTS HIGH PROBABILITY OF 1-YEAR POST-TRANSPLANT MORTALITY IN PATIENTS WITH SEVERE ACUTE-ON-CHRONIC LIVER FAILURE
- EFFECT OF THE MMAT-3 POLICY ON POST-TRANSPLANT OUTCOMES